Is EBV More Common in African Americans?; polyDNA Reviews the Literature and Recommends Gene-Eden-VIR and Novirin

• 

We believe that African Americans should talk to their doctors about Gene-Eden-VIR and Novirin if they are concerned about an EBV infection. - Mike Evans, polyDNA

Rochester, NY (PRWEB) May 26, 2014

polyDNA has learned that African Americans are infected with the Epstein Barr Virus (EBV) at higher rates, and at different ages, than other ethnicities according to several studies. For example, one study found that “Antibody prevalence (for EBV), adjusted for age and sex, was: non-Hispanic blacks, 74%; Asians, 62%, multiracial children, 54%; Hispanics, 50%; non-Hispanic whites, 26%.” (See Clinical Infectious Diseases, from May 11, 2014) (1). Another study found that “Black-white differences in EBV antibody levels were found suggesting EBV reactivation and potential disparities in immune function among minority youth.” (See the Annals of Epidemiology, from May 2013) (2). In light of the medical evidence, polyDNA recommends Gene-Eden-VIR and Novirin to African Americans. The formula of these natural antiviral products was proven to reduce symptoms associated with EBV infections in two post-marketing clinical studies that followed FDA guidelines.

The fact that EBV rates are on the rise in the African American community may be a real cause for concern. This is because EBV is linked to many diseases. For example, EBV can cause infectious mononucleosis (the kissing disease), tonsillitis, ear infections, sore throat, diarrhea, and can also cause several forms of cancer if left untreated. (See MedicineNet.com, from April 29, 2008) (3).

“Many people become infected with EBV in childhood. EBV infections in children usually do not cause symptoms, or the symptoms are not distinguishable from other mild, brief childhood illnesses. People, who get symptoms from EBV infection, usually teenagers or adults, get better in 2 to 4 weeks. However, some people may feel fatigued for several weeks or even months.” (See the CDC, from January 6, 2014) (4). In fact, EBV is linked to Chronic Fatigue Syndrome (CFS) as well. “Taken together, our study provides clear evidence that deficiency of EBV-specific immune response is present in CFS.” (See Simmaron Research, from March 10, 2014) (5).

“We believe that African Americans should talk to their doctors about Gene-Eden-VIR and Novirin if they are concerned about an EBV infection. These natural antiviral products were designed to target the latent Epstein Barr Virus.” - Mike Evans, polyDNA

As far as we know, the only two products currently available that target latent viruses such as the Epstein Barr Virus (and other latent herpesviruses) are Gene-Eden-VIR, and Novirin.

Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality, more expensive ingredients. The Novirin/Gene-Eden-VIR formula was tested in two post-marketing clinical studies published in September 2013 and March 2014, respectively, in the peer reviewed medical journal Pharmacy & Pharmacology (6).

Interested individuals can view the two published studies here, http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.

Up to 70% of those studied reported a decrease in symptoms associated with CMV infection, and users of the Novirin/Gene-Eden-VIR formula experienced an increase in overall health (6).

Each ingredient of Novirin was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the highest quality, safest, most effective natural ingredients that target latent viruses.

A second clinical study showed that the Novirin/Gene-Eden-VIR formula decreased physical and mental fatigue. (See Pharmacology & Pharmacy, from March, 2014) (7).
To learn more about Novirin and Gene-Eden-VIR, visit http://www.novirin.com and about Gene-Eden-VIR, visit http://www.gene-eden-vir.com.

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Age-Specific Prevalence of Epstein-Barr Virus Infection among Minnesota Children Effects of Race/Ethnicity and Family Environment. Published on May 11, 2014.
http://www.ncbi.nlm.nih.gov/pubmed/24820696

(2) Racial-ethnic differences in Epstein-Barr virus antibody titers among U.S. children and adolescents. Published in May 2013.
http://www.ncbi.nlm.nih.gov/pubmed/23621993

(3) MedicineNet.com - The Broad Spectrum of EBV Disease. Published April 29, 2008.
http://www.medicinenet.com/script/main/art.asp?articlekey=89105

(4) CDC - About Epstein-Barr Virus (EBV). Published January 6, 2014.
http://www.cdc.gov/epstein-barr/about-ebv.html

(5) EBV I: A Deficient Immune Response, Increased Levels of Epstein-Barr Virus Opens Up EBV Question in Chronic Fatigue Syndrome Again. Published on March 10, 2014.
http://simmaronresearch.com/2014/03/1591/

(6) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013. cbcd.net/Gene-Eden-VIR-Clinical-Study.php

(7) Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014. http://www.cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Novirin, an antiviral natural remedy that helps the immune system kill latent viruses.

PDF Print